Suppressing NF-κB and NKRF Pathways by Induced Pluripotent Stem Cell Therapy in Mice with Ventilator-Induced Lung Injury

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Liu, Yung Yang ^a,b   Li, Li Fu ^c,d   Yang, Cheng Ta ^c,d   Lu, Kai Hsi ^e,f   Huang, Chung Chi ^c,d   Kao, Kuo Chin ^c,d   Chiou, Shih Hwa ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^f CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 2; MALONALDEHYDE; NUCLEAR FACTOR KAPPA B REPRESSING FACTOR; SMALL INTERFERING RNA; SN 50; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; NKRF PROTEIN, MOUSE; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BLOOD VESSEL PERMEABILITY; CELL INFILTRATION; CONTROLLED STUDY; INFLAMMATION; LUNG EDEMA; LUNG GAS EXCHANGE; MALE; MICROVASCULATURE; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; TIDAL VOLUME; ULTRASTRUCTURE; VENTILATOR INDUCED LUNG INJURY; ANIMAL; C57BL MOUSE; INDUCED PLURIPOTENT STEM CELL; LEUKOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSPLANTATION; VENTILATOR-INDUCED LUNG INJURY;

MUS;

ANIMALS; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MICE, INBRED C57BL; NEUTROPHIL ACTIVATION; NF-KAPPA B; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TIDAL VOLUME; VENTILATOR-INDUCED LUNG INJURY;

EID: 84879487367     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066760     Document Type: Article

References (54)

1. Ricard JD, Dreyfuss D, Saumon G, (2003) Ventilator-induced lung injury. Eur Respir J 22: 2s-9s.
2. Tremblay LN, Slutsky AS, (2006) Ventilator-induced lung injury: from the bench to the bedside. Intensive Care Med 32: 24-33.
3. Li LF, Huang CC, Lin HC, Tsai YH, Quinn DA, et al. (2009) Unfractionated heparin and enoxaparin reduce high stretch ventilation-augmented lung injury- a prospective, controlled animal experiment. Crit Care 13: R108.
4. Li LF, Ouyang B, Choukroun G, Matyal R, Mascarenhas M, et al. (2003) Stretch-induced IL-8 depends on c-Jun NH2-terminal and nuclear factor-kappaB-inducing kinases. Am J Physiol Lung Cell Mol Physiol 285: L464-475.
5. Li LF, Yu L, Quinn DA, (2004) Ventilation-induced neutrophil infiltration depends on c-Jun N-terminal kinase. Am J Respir Crit Care Med 169: 518-524.
6. Abraham E, (2000) NF-kappa B activation. Crit Care Med 28: N100-104.
7. Zingarelli B, Sheehan M, Wong HR, (2003) Nuclear factor-kappa B as a therapeutic target in critical care medicine. Crit Care Med 31: S105-111.
8. Wright JG, Christman JW, (2003) The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. Am J Respir Med 2: 211-219.
9. Moine P, McIntyre R, Schwartz MD, Kaneko D, Shenkar R, et al. (2000) NF-kappa B regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 13: 85-91.
10. Liu YY, Liao SK, Huang CC, Tsai YH, Quinn DA, et al. (2009) Role for nuclear factor-kappa B in augmented lung injury because of interaction between hyperoxia and high stretch ventilation. Transl Res 154: 228-240.
11. Ning Q, Wang X, (2007) Role of Rel A and IkappaB of nuclear factor kappaB in the release of interleukin-8 by cyclic mechanical strain in human alveolar type II epithelial cells A549. Respirology 12: 792-798.
12. Uhlig U, Haitsma JJ, Goldmann T, Poelma DL, Lachmann B, et al. (2002) Ventilation-induced activation of the mitogen-activated protein kinase pathway. Eur Respir J 20: 946-956.
13. Held HD, Boettcher S, Hamann L, Uhlig S, (2001) Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-kappa B and is blocked by steroids. Am J Respir Crit Care Med 163: 711-716.
14. Froese N, Schwarzer M, Niedick I, Frischmann U, Köster M, et al. (2006) Innate immune responses in NF-kappa B-repressing factor-deficient mice. Mol Cell Biol 26: 293-302.
15. Nourbakhsh M, Hauser H, (1999) Constitutive silencing of IFN-beta promoter is mediated by NRF (NF-kappa B-repressing factor), a nuclear inhibitor of NF-kappaB. EMBO J 18: 6415-6425.
16. Feng X, Guo Z, Nourbakhsh M, Hauser H, Ganster R, et al. (2002) Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS gene. Proc Natl Acad Sci USA 99: 14212-14217.
17. Reboll MR, Schweda AT, Bartels M, Franke R, Frank R, et al. (2011) Mapping of NRF binding motifs of NF-kappa B p65 subunit. J Biochem 150: 553-562.
18. Nourbakhsh M, Kalble S, Dorrie A, Hauser H, Resch K, et al. (2001) The NF-kappa B repressing factor is involved in basal repression and interleukin (IL)-1-induced activation of IL-8 transcription by binding to a conserved NF-kappa B-flanking sequence element. J Biol Chem 276: 4501-4508.
19. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M, (2002) Multiple control of interleukin-8 gene expression. J Leukoc Biol 72: 847-855.
20. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, et al. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146.
21. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
22. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
23. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
24. Chen SJ, Chang CM, Tsai SK, Chang YL, Huang SS, et al. (2010) Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev 19: 1757-1767.
25. Yang KY, Shih HC, How CK, Chen CY, Hsu HS, et al. (2011) IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in mice. Chest 140: 1243-1253.
26. Curley GF, Hayes M, Ansari B, Shaw G, Ryan A, et al. (2012) Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 67: 496-501.
27. Li HY, Chien Y, Chen YJ, Chen SF, Chang YL, et al. (2011) Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells. Biomaterials 32: 5994-6005.
28. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, et al. (2009) Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med 179: 220-227.
29. Tsuji O, Miura K, Okada Y, Fujiyoshi K, Mukaino M, et al. (2010) Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci USA 107: 12704-12709.
30. Miki K, Uenaka H, Saito A, Miyagawa S, Sakaguchi T, et al. (2012) Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats. Stem Cells Transl Med 1: 430-437.
31. Abreu SC, Antunes MA, Pelosi P, Morales MM, Rocco PRM, (2011) Mechanisms of cellular therapy in respiratory diseases. Intensive Care Med 37: 1421-1431.
32. Mou H, Zhao R, Sherwood R, Ahfeldt T, Lapey A, et al. (2012) Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. Cell Stem Cell 10: 385-397.
33. Kadzik RS, Morrisey EE, (2012) Directing lung endoderm differentiation in pluripotent stem cells. Cell Stem Cell 10: 355-361.
34. Araújo IM, Abreu SC, Maron-Gutierrez T, Cruz F, Fujisaki L, et al. (2010) Bone marrow-derived mononuclear cell therapy in experimental pulmonary and extrapulmonary acute lung injury. Crit Care Med 38: 1733-1741.
35. Rojas M, Xu J, Woods CR, Mora AL, Spears W, et al. (2005) Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33: 145-152.
36. Gupta N, Su X, Popov B, Lee JW, Serikov V, et al. (2007) Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179: 1855-1863.
37. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA, (2009) Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 106: 16357-16362.
38. Abraham E, (2003) Neutrophils and acute lung injury. Crit Care Med 31: S195-199.
39. Park HS, Kim SR, Lee YC, (2009) Impact of oxidative stress on lung diseases. Respirology 14: 27-38.
40. Syrkina O, Jafari B, Hales CA, Quinn DA, (2008) Oxidant stress mediates inflammation and apoptosis in ventilator-induced lung injury. Respirology 13: 333-340.
41. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E, (2004) Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 172: 2522-2529.
42. Yang H, Wen Y, Bin J, Hou-You Y, Yu-Tong W, (2011) Protection of bone marrow mesenchymal stem cells from acute lung injury induced by paraquat poisoning. Clin Toxicol 49: 298-302.
43. Yagi H, Soto-Gutierrez A, Navarro-Alvarez N, Nahmias Y, Goldwasser Y, et al. (2010) Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther 18: 1857-1864.
44. Schmitz ML, Bacher S, Kracht M, (2001) I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends Biochem Sci 26: 186-190.
45. Ho SC, Lee KY, Chan YF, Kuo LW, Ito K, et al. (2009) Neutrophil elastase represses IL-8/CXCL8 synthesis in human airway smooth muscle cells through induction of NF-kappa B repressing factor. J Immunol 183: 411-420.
46. Lee KY, Ho SC, Chan YF, Wang CH, Huang CD, et al. (2012) Reduced nuclear factor-κB repressing factor: a link toward systemic inflammation in COPD. Eur Respir J 40: 863-873.
47. Nussbaum J, Minami E, Laflamme MA, Virag JA, Ware CB, et al. (2007) Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 21: 1345-1357.
48. Matthay MA, Thompson BT, Read EJ, McKenna DH, Liu KD, et al. (2010) Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest 138: 965-972.
49. Lee JW, Gupta N, Serikov V, Matthay MA, (2009) Potential application of mesenchymal cells in acute lung injury. Expert Opin Biol Ther 9: 1259-1270.
50. Aggarwal S, Pittenger MF, (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822.
51. Stagg J, (2007) Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens 69: 1-9.
52. Hegeman MA, Hennus MP, van Meurs M, Cobelens PM, Kavelaars A, et al. (2010) Angiopoietin-1 treatment reduces inflammation but does not prevent ventilator-induced lung injury. PLoS ONE 5: e15653.
53. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, et al. (2003) Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 167: 1027-1035.
54. Otte JM, Mahjurian-Namari R, Brand S, Werner I, Schmidt WE, et al. (2009) Probiotics regulate the expression of COX-2 in intestinal epithelial cells. Nutr Cancer 61: 103-113.